![]()
MIRA INFORM REPORT
|
Report Date : |
26.02.2011 |
IDENTIFICATION DETAILS
|
Name : |
GEMINI INDÚSTRIA DE INSUMOS FARMACÊUTICOS
LTDA |
|
|
|
|
Registered Office : |
Via Primária 4d, S/Nº, Quadra 08a, Módulos I E Ii - Daia , Zip Code 75133-590 - Anápolis/Go |
|
|
|
|
Country : |
|
|
|
|
|
Financials (as on) : |
31.12.2010 |
|
|
|
|
Date of Incorporation : |
23.01.2009 |
|
|
|
|
Legal Form : |
Limited Liability Company |
|
|
|
|
Line of Business : |
Manufacture, Import and Distribution of Pharmaceutical Products |
RATING & COMMENTS
|
MIRA’s Rating : |
B |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively below
average. |
Small |
|
Maximum Credit Limit : |
USD 100.000,00 |
|
|
|
|
Status : |
New Company |
|
|
|
|
Payment
Behaviour : |
Regular |
|
|
|
|
Litigation : |
Clear |
NOTES :
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – June 30, 2010
|
Country Name |
Previous Rating (01.04.2010) |
Current Rating (30.06.2010) |
|
|
a2 |
a2 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
GEMINI INDÚSTRIA
DE INSUMOS FARMACÊUTICOS LTDA
|
MAIN ADDRESS: |
VIA PRIMÁRIA 4D, S/Nº, QUADRA 08A, MÓDULOS I |
|
ZIP CODE/CITY: |
75133-590 - ANÁPOLIS/GO |
|
|
|
|
PHONE: |
11 2067-5610 |
|
FAX: |
11 2215-8823 |
|
E-MAIL: |
|
BRANCHES: |
|
NOT AVAILABLE. |
|
MAIN ACTIVITIES: |
|
MANUFACTURE, IMPORT AND DISTRIBUTION OF PHARMACEUTICAL PRODUCTS. |
|
LEGAL FORM: |
LIMITED
LIABILITY COMPANY |
|
|
|
|
INCORPORATION DATE: |
23/01/2009 |
|
REGISTER DATE: |
12/03/2009 |
|
BALANCE SHEET FILING DATE: |
31/12 |
|
TAX CONTRIBUTOR NUMBER (CNPJ): |
10.690.195/0001-00 |
|
STATE REGISTER: |
10.450.596-6 |
|
|
|
|
SHARE CAPITAL: |
R$ 3.000.000,00 |
|
PAID UP CAPITAL: |
R$ 2.381.000,00 |
|
BOARD OF
DIRECTORS: |
|
|
|
|
|
IVAN DA GLÓRIA TEIXEIRA |
DIRECTOR |
|
THE DIRECTOR IS AUTHORIZED TO SIGN ON BEHALF OF THE COMPANY. |
|
SHAREHOLDERS /
PARTNERS: |
|
|
|
|
|
JÚLIO TOMIZO TANAKA |
50% |
|
VALDETE VIODRES TANAKA |
50% |
|
AFFILIATES /
SUBSIDIARIES: |
|
|
|
LEVIALE INDÚSTRIA COSMÉTICA LTDA |
|
GENIX - INDÚSTRIA FARMACÊUTICA LTDA |
|
THE SUBJECT WAS ESTABLISHED ON JANUARY 23, 2009 TO BE ENGAGED IN THE SAID
LINE OF BUSINESS AND UP TO DATE IT IS STILL OPERATING WITHIN THE GENERAL
SCENE REPORTED HEREIN. THE COMPANY OPERATES WITH THE TRADE NAME "GEMINI INDÚSTRIA E
COMÉRCIO LTDA". FURTHER DETAILS ARE SO FAR NOT KNOWN. |
|
PUBLIC
INFORMATION: |
|
NO DETRIMENTAL FILES WERE FOUND. |
|
GENERAL BALANCE SHEETS AS OF 31/12/2010 AND 31/12/2009. |
|
( FIGURES ARE IN REAIS ). |
|
ASSETS |
|
|
|
|
CURRENT: |
31/12/2010 |
31/12/2009 |
|
|
|
|
|
|
|
CASH |
95,71 |
673,67 |
|
|
BANKS |
70.721,09 |
5.586,65 |
|
|
ADVANCES |
33.229,51 |
7.474,17 |
|
|
CLIENTS |
541.528,98 |
|
|
|
RECOVERABLE TAXES |
15.234,02 |
|
|
|
INVENTORY |
1.239.166,25 |
|
|
|
|
---------------- |
---------------- |
|
|
TOTAL CURRENT ASSETS |
1.899.975,56 |
13.734,49 |
|
|
FIXED ASSETS: |
|
|
|
|
|
|
|
|
|
FIXED ASSETS |
910.579,94 |
840.005,25 |
|
|
DEFERRED |
200.384,80 |
33.348,80 |
|
|
|
---------------- |
---------------- |
|
|
TOTAL FIXED ASSETS |
1.110.964,74 |
873.354,05 |
|
|
|
================ |
================ |
|
|
TOTAL ASSETS |
3.010.940,30 |
887.088,54 |
|
|
LIABILITIES: |
|
|
|
|
CURRENT: |
31/12/2010 |
31/12/2009 |
|
|
|
|
|
|
|
SALARIES PAYABLE |
7.307,92 |
4.088,87 |
|
|
SOCIAL OBLIGATIONS |
5.214,50 |
3.667,33 |
|
|
PROVISIONS |
9.985,93 |
1.773,17 |
|
|
TAXES & CONTRIBUTIONS |
117.748,27 |
1.813,87 |
|
|
ACCOUNTS PAYABLE |
1.385,85 |
34.745,30 |
|
|
SUPPLIERS |
644.223,16 |
|
|
|
|
---------------- |
---------------- |
|
|
TOTAL CURRENT LIABILITIES |
785.865,63 |
46.088,54 |
|
|
LONG TERM
LIABILITIES: |
|
|
|
|
|
|
|
|
|
LOANS AND FINANCING |
124.487,07 |
|
|
|
|
---------------- |
---------------- |
|
|
TOTAL LONG TERM LIABILITIES |
124.487,07 |
|
|
|
NET EQUITY: |
|
|
|
|
|
|
|
|
|
SHARE CAPITAL |
2.381.000,00 |
841.000,00 |
|
|
PROFIT (LOSS) OF PERIOD |
-280.412,40 |
|
|
|
|
---------------- |
---------------- |
|
|
TOTAL NET EQUITY |
2.100.587,60 |
841.000,00 |
|
|
|
================ |
================ |
|
|
TOTAL LIABILITIES |
3.010.940,30 |
887.088,54 |
|
|
PROFIT AND LOSS ACCOUNTS AS OF 31/12/2010 AND 31/12/2009. |
|
( FIGURES ARE IN REAIS ). |
|
|
31/12/2010 |
31/12/2009 |
|
|
|
|
|
|
|
GROSS SALES |
1.742.609,70 |
|
|
|
(-) TAXES ON SALES |
243.364,18 |
|
|
|
|
---------------- |
---------------- |
|
|
NET SALES |
1.499.245,52 |
|
|
|
(-) COST OF SOLD GOODS |
1.575.577,80 |
|
|
|
|
---------------- |
---------------- |
|
|
GROSS PROFIT |
-76.332,28 |
|
|
|
OPERATING REVENUE (EXPENSE) |
-220.213,95 |
|
|
|
FINANCIAL REVENUE(EXPENSE) |
16.133,83 |
|
|
|
|
---------------- |
---------------- |
|
|
OPERATIONAL PROFIT (LOSS) |
-280.412,40 |
|
|
|
|
---------------- |
---------------- |
|
|
NET PROFIT (LOSS) |
-280.412,40 |
|
|
|
MONTHLY SALES |
|||
|
|
2010 |
|
|
|
|
--------------------- |
|
|
|
JANUARY |
|
|
|
|
FEBRUARY |
|
|
|
|
MARCH |
|
|
|
|
APRIL |
|
|
|
|
MAY |
|
|
|
|
JUNE |
|
|
|
|
JULY |
|
|
|
|
AUGUST |
|
|
|
|
SEPTEMBER |
R$ 55.445,00 |
|
|
|
OCTOBER |
R$ 824.193,60 |
|
|
|
NOVEMBER |
R$ 350.914,40 |
|
|
|
DECEMBER |
R$ 512.056,70 |
|
|
|
TOTAL |
R$ 1.742.609,70 |
|
|
|
RATIOS: |
31/12/2010 |
31/12/2009 |
|
|
QUICK RATIO |
,84 |
|
,30 |
|
|
|
|
CURRENT RATIO |
2,42 |
|
,30 |
|
|
|
|
ACCOUNTS RECEIVABLE TURNOVER |
2,77 |
TIMES |
|
|
|
|
|
DAYS' SALES IN RECEIVABLES |
130,03 |
DAYS |
|
|
|
|
|
INVENTORY TURNOVER |
1,27 |
TIMES |
|
|
|
|
|
ACCOUNTS PAYABLE PERIOD |
147,20 |
DAYS |
|
|
|
|
|
RETURN ON ASSETS |
,50 |
TIMES |
|
|
|
|
|
SALES TURNOVER ON NET EQUITY |
,71 |
TIMES |
|
|
|
|
|
NET WORTH TIE-UP |
,43 |
|
1,00 |
|
|
|
|
INDEBTEDNESS |
,43 |
|
,05 |
|
|
|
|
EQUITY RATIO |
69,77 |
% |
94,80 |
% |
|
|
|
WORKING CAPITAL RATIO |
141,77 |
% |
-70,20 |
% |
|
|
|
GENERAL SOLVENCY |
3,31 |
|
19,25 |
|
|
|
|
RETURN ON NET EQUITY |
-13,35 |
% |
|
|
|
|
|
RETURN ON SALES (PROFIT MARGIN) |
-18,70 |
% |
|
|
|
|
|
GROSS PROFIT MARGIN |
-5,09 |
% |
|
|
|
|
|
OPERATIONAL RESULT |
-18,70 |
% |
|
|
|
|
|
SALES TURNOVER ON LIABILITIES |
1,91 |
TIMES |
|
|
|
|
|
FOREIGN CURRENCY ON ASSETS |
|
|
|
|
|
|
|
FOREIGN CURRENCY ON LIABILITIES |
|
|
|
|
|
|
|
EXCHANGE RATE: |
|
|
US$ 1,00 = R$ 1,67 |
- OFFICIAL RATE ON 23/02/2011 |
|
US$ 1,00 = R$ 1,66 |
- OFFICIAL RATE ON 31/12/2010 |
|
US$ 1,00 = R$ 1,74 |
- OFFICIAL RATE ON 31/12/2009 |
|
COMMENTS ON THE
FINANCIAL INFORMATION: |
|
FOLLOWS ATTACHED WORKSHEET WITH MAIN FINANCIAL RATIOS. THE FIGURES AVAILABLE SHOW A SATISFACTORY FINANCIAL STANDING. THE
LEVEL OF INDEBTEDNESS IS LOW AND IT IS NOTED GOOD CURRENT RATIO AND POSITIVE WORKING
CAPITAL AMOUNT. IN ADDITION IT ALREADY SHOWS AN INTERESTING SALES VOLUME
BUT NEGATIVE RESULT WAS MADE. REMARK: THE 2009 PROFIT AND LOSS ACCOUNT IS NOT AVAILABLE DUE TO THE
FACT THAT THE COMPANY STARTED ITS OPERATIONS IN 2010 ONLY. |
|
REAL ESTATE: |
NOT AVAILABLE.
|
VEHICLES: |
NOT AVAILABLE.
|
MACHINES: |
NOT AVAILABLE.
|
NOT AVAILABLE. |
|
|
BRANCH/PHONE: |
|
BANCO DO BRASIL S/A |
3388-X / 62 3311-1633 |
|
REMARKS: IN ACCORDING TO THE CENTRAL BANK OF |
|
MANUFACTURE, IMPORT AND DISTRIBUTION OF PHARMACEUTICAL PRODUCTS. |
|
IMPORT AND
EXPORT: |
IMPORTS FROM:
|
NOT AVAILABLE. |
EXPORTS TO:
|
NOT AVAILABLE. |
|
MAIN CLIENTS: |
|
|
|
NOT AVAILABLE. |
|
STAFF: |
|
|
|
THE COMPANY HAS: 3 EMPLOYEES |
|
THE SUBJECT IS A NEWLY-ESTABLISHED COMPANY, OPERATING SINCE 2009. SO FAR
IT HAS A CLEAR TRADE HISTORY AND MODEST PAYMENT BEHAVIOUR. THE COMPANY HAS TRADE RELATIONS WITH SOME LOCAL SUPPLIERS BUT UP TO
DATE ONLY SMALL PAYMENTS WERE REPORTED AND THE SUBJECT IS NOT SAID TO BE USER
OF TRADE CREDIT FACILITIES. |
|
MAIN SUPPLIERS: |
|
|
|
NOT AVAILABLE. |
|
PAYMENT HISTORY: |
|
1 SUPPLIER REPORTED PAYMENTS: |
|
TOTAL AMOUNT: R$ 1.044,00 |
|
|
|
AMOUNT OF INVOICES PAID: 3 |
|
TOTAL OF PROMPT PAYMENTS: 100% |
|
BASED ON THE OVERALL DATA AVAILABLE THE SUBJECT MAY BE CONSIDERED FOR A CREDIT LIMIT OF USD 100.000,00 MAY BE GRANTED. |

FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.45.37 |
|
|
1 |
Rs.73.25 |
|
Euro |
1 |
Rs.62.68 |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively below
average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a composite
of weighted scores obtained from each of the major sections of this report. The
assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.